Sex differences in long-term clinical outcomes following modified electroconvulsive therapy for major depressive disorder

Modified electroconvulsive therapy (MECT) is one of the most effective treatments for patients with major depressive disorder (MDD). This study aimed to examine sex differences in long-term clinical outcomes following MECT in patients with MDD. Clinical data were obtained from mental health centers and psychiatric hospitals across seven provinces participating in the MECT study. Suicide risk and depressive symptoms were assessed using the suicidal module of the Mini International Neuropsychiatric Interview (MINI-C) and the 17-item Hamilton Rating Scale for Depression (HAMD-17), respectively. The efficacy of MECT was evaluated using the Clinical Global Impressions (CGI) scale and the Visual Analogue Scale (VAS). Participants were assessed at five time points: before the first MECT session, postassessment, at 2-week, 1-month, and 6-month follow-ups. Generalized estimating equations were employed to model the longitudinal trajectories of MINI-C and HAMD-17 scores across repeated assessments. The study included 133 patients with MDD (48 males, 36.1%; 85 females, 63.9%). Longitudinal analysis revealed a significant sex-by-time interaction for HAMD-17 scores ( p < 0.05), indicating that the trajectory of depressive symptom improvement differed between males and females. Although no significant sex difference was found in the trajectory of suicide risk (MINI-C) ( χ² = 5.525, p = 0.238), post-hoc comparisons showed that females derived a greater long-term benefit from MECT, with significantly lower HAMD-17 scores at the 6-month follow-up (adjusted mean difference = 2.47, p = 0.042). Regarding treatment response, females reported significantly higher VAS scores than males at the 6-month follow-up (88 vs. 85, Z = -2.906, p = 0.002). These findings suggest that sex may be associated with differential long-term clinical outcomes following MECT, although causal attribution is limited by the observational study design.

Authors

Institutions

Publication Details

Journal
BMC Psychiatry
Published
2026-11-03
DOI
https://doi.org/10.1186/s12888-026-08831-2
Primary Topic
Electroconvulsive Therapy Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex differences in long-term clinical outcomes following modified electroconvulsive therapy for major depressive disorder

Yanni Wang, 雪莲 张, Lijuan Huo, Xuan LEI et al.
BMC Psychiatry
Electroconvulsive Therapy Studies
article

Sex differences in long-term clinical outcomes following modified electroconvulsive therapy for major depressive disorder

Yanni Wang, 雪莲 张, Lijuan Huo, Xuan LEI, Xiaoli Huan, 王杰思, Yongjie Zhou, Xuejun Li, Yang Wang
article en

Abstract

Modified electroconvulsive therapy (MECT) is one of the most effective treatments for patients with major depressive disorder (MDD). This study aimed to examine sex differences in long-term clinical outcomes following MECT in patients with MDD. Clinical data were obtained from mental health centers and psychiatric hospitals across seven provinces participating in the MECT study. Suicide risk and depressive symptoms were assessed using the suicidal module of the Mini International Neuropsychiatric Interview (MINI-C) and the 17-item Hamilton Rating Scale for Depression (HAMD-17), respectively. The efficacy of MECT was evaluated using the Clinical Global Impressions (CGI) scale and the Visual Analogue Scale (VAS). Participants were assessed at five time points: before the first MECT session, postassessment, at 2-week, 1-month, and 6-month follow-ups. Generalized estimating equations were employed to model the longitudinal trajectories of MINI-C and HAMD-17 scores across repeated assessments. The study included 133 patients with MDD (48 males, 36.1%; 85 females, 63.9%). Longitudinal analysis revealed a significant sex-by-time interaction for HAMD-17 scores ( p < 0.05), indicating that the trajectory of depressive symptom improvement differed between males and females. Although no significant sex difference was found in the trajectory of suicide risk (MINI-C) ( χ² = 5.525, p = 0.238), post-hoc comparisons showed that females derived a greater long-term benefit from MECT, with significantly lower HAMD-17 scores at the 6-month follow-up (adjusted mean difference = 2.47, p = 0.042). Regarding treatment response, females reported significantly higher VAS scores than males at the 6-month follow-up (88 vs. 85, Z = -2.906, p = 0.002). These findings suggest that sex may be associated with differential long-term clinical outcomes following MECT, although causal attribution is limited by the observational study design.

BMC Psychiatry
Shenzhen University (CN), South China Normal University (CN), Chinese Academy of Sciences (CN), Shenzhen Maternity and Child Healthcare Hospital (CN), Gansu Provincial Hospital (CN), Gansu Provincial Maternal and Child Health Hospital (CN), Institute of Psychology, Chinese Academy of Sciences (CN), Lanzhou University (CN)
Openalex Percentile: Top 14%
Electroconvulsive Therapy Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon